List of LipoScience patents

List of LipoScience patents

List of Arog Pharmaceuticals, Inc. patents

List of Infantino patents

List of Innosense Llc patents

List of funding rounds for Orezone Gold Corporation

List of genetic testing patents

Patents where

Current Assignee

Name

is

LipoScience

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9483611 Protective HDL particle number evaluations	Patent 9483611 was granted and assigned to LipoScience on November, 2016 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9483611	November 1, 2016
	‌ US Patent 9470771 NMR measurements of NMR biomarker GlycA	Patent 9470771 was granted and assigned to LipoScience on October, 2016 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9470771	October 18, 2016
	‌ US Patent 9361429 Multi-parameter diabetes risk evaluations	Patent 9361429 was granted and assigned to LipoScience on June, 2016 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9361429	June 7, 2016
	‌ US Patent 9435870 Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements	Patent 9435870 was granted and assigned to LipoScience on September, 2016 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	9435870	September 6, 2016
	‌ US Patent 9792410 Multi-parameter diabetes risk evaluations	Patent 9792410 was granted and assigned to LipoScience on October, 2017 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9792410	October 17, 2017
	‌ US Patent 7243030 Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals	Patent 7243030 was granted and assigned to LipoScience on July, 2007 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	7243030	July 10, 2007
	‌ US Patent 8013602 NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples	Patent 8013602 was granted and assigned to LipoScience on September, 2011 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	8013602	September 6, 2011
	‌ US Patent 7790465 Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements	Patent 7790465 was granted and assigned to LipoScience on September, 2010 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	7790465	September 7, 2010
	‌ US Patent 8704521 NMR analyzers for clinical evaluation of biosamples	Patent 8704521 was granted and assigned to LipoScience on April, 2014 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	8704521	April 22, 2014
	‌ US Patent 10365339 NMR analyzers for clinical evaluation of biosamples	Patent 10365339 was granted and assigned to LipoScience on July, 2019 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	10365339	July 30, 2019
	‌ US Patent 9483612 CHD risk stratification evaluations for subjects with high levels of large HDL-P	Patent 9483612 was granted and assigned to LipoScience on November, 2016 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9483612	November 1, 2016
	‌ US Patent 8386187 Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same	Patent 8386187 was granted and assigned to LipoScience on February, 2013 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	8386187	February 26, 2013
	‌ US Patent 9541620 NMR quantification of TMAO	Patent 9541620 was granted and assigned to LipoScience on January, 2017 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9541620	January 10, 2017
	‌ US Patent 9535144 NMR quantification of TMAO	Patent 9535144 was granted and assigned to LipoScience on January, 2017 by the United States Patent and Trademark Office.	LipoScience	LipoScience		United States Patent and Trademark Office	9535144	January 3, 2017
	‌ US Patent 9689942 Quantitative NMR clinical analyzers with automatic NMR temperature sensitivity compensation that accommodate large ambient operational temperature ranges	Patent 9689942 was granted and assigned to LipoScience on June, 2017 by the United States Patent and Trademark Office.		LipoScience		United States Patent and Trademark Office	9689942	June 27, 2017

15 results

0 selected

15 results

0 selected